Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy
Identifying pathways that cause pathological cardiac hypertrophy holds great therapeutic potential. Here the authors discover one such pathway and show that SIKE, an inhibitor of interferon signalling, prevents pathological but not physiological cardiac hypertrophy by interacting with TBK1 and modul...
Guardado en:
Autores principales: | Ke-Qiong Deng, Aibing Wang, Yan-Xiao Ji, Xiao-Jing Zhang, Jing Fang, Yan Zhang, Peng Zhang, Xi Jiang, Lu Gao, Xue-Yong Zhu, Yichao Zhao, Lingchen Gao, Qinglin Yang, Xue-Hai Zhu, Xiang Wei, Jun Pu, Hongliang Li |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3a0ceb3a62dc4aea8e77bd44a26b3573 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling
por: Yan-Xiao Ji, et al.
Publicado: (2016) -
ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia
por: Jean-Baptiste Micol, et al.
Publicado: (2017) -
ANGPTL8 negatively regulates NF-κB activation by facilitating selective autophagic degradation of IKKγ
por: Yu Zhang, et al.
Publicado: (2017) -
Histone lysine dimethyl-demethylase KDM3A controls pathological cardiac hypertrophy and fibrosis
por: Qing-Jun Zhang, et al.
Publicado: (2018) -
A new method for the discovery of essential proteins.
por: Xue Zhang, et al.
Publicado: (2013)